4//SEC Filing
ProUroCare Medical Inc. 4
Accession 0001179110-13-016968
CIK 0001222244operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 9:52 AM ET
Size
22.7 KB
Accession
0001179110-13-016968
Insider Transaction Report
Form 4
Reiling William
10% Owner
Transactions
- Purchase
Convertible Note
2013-07-01Exercise: $0.50From: 2013-07-01Exp: 2014-07-01→ Common Stock - Award
Warrants
2013-09-02+100,000→ 100,000 totalExercise: $0.50From: 2013-09-20Exp: 2016-09-20→ Common Stock (100,000 underlying) - Purchase
Warrant
2013-07-01+100,000→ 100,000 totalExercise: $0.50From: 2013-07-01Exp: 2016-07-01→ Common Stock (100,000 underlying) - Other
Convertible Note
2013-09-02Exercise: $1.30Exp: 2015-03-31→ Common Stock, $0.00001 par value - Award
Warrants
2013-09-20+100,000→ 100,000 totalExercise: $0.50From: 2013-09-20Exp: 2017-03-31→ Common Stock (100,000 underlying) - Other
Convertible Note
2013-09-02Exercise: $1.30Exp: 2014-09-20→ Common Stock, $0.00001 par value
Holdings
- 1,116,080
Common Stock, $0.00001 par value
- 295,313
Warrants
Exercise: $0.50From: 2013-05-08Exp: 2018-05-08→ Common Stock, $0.00001 par value (295,313 underlying) - 291,670
Warrants
Exercise: $0.50From: 2013-05-08Exp: 2018-05-08→ Common Stock, $0.00001 par value (291,670 underlying) - 145,998
Warrants
Exercise: $0.50From: 2013-05-08Exp: 2018-05-08→ Common Stock, $0.00001 par value (145,998 underlying)
Footnotes (7)
- [F1]The Reporting Person holds $100,000 of 10% convertible secured subordinated promissory notes from the Issuer. The promissory note and any accrued interest thereon is convertible at any time at the option of the reporting person into common stock at $1.30 per share. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The Issuer's directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
- [F2]The issuer issued the warrants to the Reporting Person as consideration for a $450,000 loan guarantee for the period from April 1, 2013 to February 15, 2014. The warrants will vest as to 28,125 shares on the first of each month from April 2013 to January, 201], and as to 14,063 shares on February 1, 2014, subject to adjustment if the amount of the loan guaranteed should change. The issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
- [F3]The Reporting Person agreed to accept the warrants in lieu of cash repayment of $56,833 of advances made by the Reporting Person to the Issuer. The Issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
- [F4]The issuer issued the warrants to the Reporting Person as consideration for a $500,000 loan guarantee for the period from November 1, 2012 to March 31, 2013. The Issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
- [F5]Currently exercisable in full.
- [F6]The Issuer issued the warrants to the Reporting Person as consideration for extending the expiration date of the Convertible Note for a period of one year to September 20, 2014.
- [F7]The Issuer issued the warrants to the Reporting Person as consideration for extending the expiration date of the Convertible Note for a period of one year to March 31, 2015.
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001222244
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 9:52 AM ET
- Size
- 22.7 KB